Cutler Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-803
| Closed | -$40K | – | 2722 |
|
|
2021
Q4 | $40K | Buy |
+803
| New | +$40K | ﹤0.01% | 1266 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2187 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2271 |
|
|
2019
Q2 | – | Sell |
-200
| Closed | -$10K | – | 2323 |
|
|
2019
Q1 | $10K | Hold |
200
| – | – | ﹤0.01% | 1200 |
|
|
2018
Q4 | $8K | Sell |
200
-200
| -50% | -$8K | ﹤0.01% | 1298 |
|
|
2018
Q3 | $27K | Buy |
400
+100
| +33% | +$6.75K | ﹤0.01% | 1104 |
|
|
2018
Q2 | $22K | Sell |
300
-100
| -25% | -$7.33K | ﹤0.01% | 1114 |
|
|
2018
Q1 | $21K | Buy |
400
+300
| +300% | +$15.8K | ﹤0.01% | 1189 |
|
|
2017
Q4 | $5K | Sell |
100
-3,261
| -97% | -$163K | ﹤0.01% | 1820 |
|
|
2017
Q3 | $200K | Buy |
3,361
+1,579
| +89% | +$94K | 0.01% | 754 |
|
|
2017
Q2 | $140K | Buy |
1,782
+1,682
| +1,682% | +$132K | 0.01% | 1029 |
|
|
2017
Q1 | $8K | Sell |
100
-1,944
| -95% | -$156K | ﹤0.01% | 2247 |
|
|
2016
Q4 | $162K | Buy |
+2,044
| New | +$162K | 0.01% | 950 |
|
|
2016
Q3 | – | Sell |
-2,849
| Closed | -$110K | – | 3481 |
|
|
2016
Q2 | $110K | Buy |
2,849
+1,547
| +119% | +$59.7K | 0.01% | 968 |
|
|
2016
Q1 | $52K | Sell |
1,302
-1,367
| -51% | -$54.6K | ﹤0.01% | 1283 |
|
|
2015
Q4 | $236K | Buy |
+2,669
| New | +$236K | 0.01% | 626 |
|